What’s Holding Up THC Breathalyzers?
Bethan Jenkins
April 25th, 2018
Policy
Driving under the influence of something that impairs reactions is a serious offence. While there are alcohol breathalyzers to detect when a motorist has been knocking back the booze before taking to the open roads, what about drivers who use cannabis prior to getting behind the wheel? Well, it might have taken a while, but THC breathalyzers are officially here.
Don’t get too excited just yet, however. These devices are still being developed and since they are in the infantile stages, there’s a long way to go until law enforcement and the judicial system can accurately measure and enforce cannabis intoxication.
What is a THC Breathalyzer?
A THC breathalyzer is designed to detect the levels of tetrahydrocannabinol (THC) in a person’s blood. These unique devices could potentially transform the way in which cannabis intoxication is enforced in the future.
In order to effectively measure blood levels based on a person’s breath, it is essential to understand what the vapor pressure is. The way in which a compound reacts when transitioning from a liquid to a gas is known as its vapor pressure. This is precisely what happens inside the lungs when a molecule leaves the blood to be exhaled in a person’s breath.
Unlike traditional breathalyzers that detect the blood alcohol content (BAC), a cannabis breathalyzer detects the psychoactive THC compound. These incredibly useful tools can function with an impressive time range. Some THC breathalyzers will reveal THC ingestion within half an hour, whereas others may take up to two hours to show a precise vapor reading.
Who Needs THC Breathalyzers?
The police department can benefit from THC breathalyzers, since these tools can help them to punish people who commit cannabis DUIs. Governments and law enforcement can also benefit from impairment-testing mechanisms, with the governor of Vermont being one of the first to express his desire for the invention of a reliable THC breathalyzer.
How Do THC Breathalyzers Work?
A specific type of chemistry is used to determine how much THC is contained in a person’s body when the molecule is exhaled in their breath. Think about it like this – if you are able to figure out the amount of pressure produced by ethanol vapor, you can successfully calculate the amount of ethanol that remains in a bottle based on the properties of the gases.
This logic is exactly the same for the THC that leaves the human body. THC-testing devices work by measuring the vapor pressure of the cannabis compound. Since THC is such a complex molecule, scientists have faced many hurdles in developing cannabis breathalyzers.
Are there any common problems associated with THC breath testing technologies?
The main issue with THC breathalyzers is that the majority of devices in development simply measure the amount of THC, rather than a person’s behavior when under the influence. It is tricky to understand whether or not a person is incapable of operating a motor vehicle in this way.
Scientists are still uncertain on what amount of THC is too much to drive. However, certain states (such as Colorado) deem five nanograms of THC to be too much. The Associate Professor of Laboratory Medicine at the University of California San Francisco, Kara Lynch, says there will be ongoing studies to analogize impaired breath levels and confirm a standard.
What is the typical timeline for product development?
Research and development into THC breathalyzers has been taking place for years, but thankfully, we’re getting somewhere. Recently, the National Institute of Standards and Technology (NIST) published the results of a study on the fundamental physical properties of delta-9 tetrahydrocannabinol (THC) in Forensic Chemistry.
Their results showed how the vapor pressure of THC was successfully measured – a breakthrough for scientists, who have struggled to accomplish this task in the past due to THC’s complexity and size. The timeline for THC breathalyzer development will now be a lot shorter than it has been in the past.
Why is Cannabix Technologies a leading name in THC breathalyzer development?
Based in Vancouver, B.C., Cannabix Technologies Inc. is a technology company responsible for developing the Cannabix Marijuana Breathalyzer. Similar to the roadside devices used to detect alcohol on the breath of drunk drivers, the Cannabix Marijuana Breathalyzer exposes THC in breath.
Cannabix is capitalizing on a time when cannabis is becoming legal in many places around the world, by developing quality breath testing technologies that detect the cannabis plant’s psychoactive component – Tetrahydrocannabinol (THC). The recent use of cannabis can be identified using Cannabix’s tool, which identifies the level of THC molecules.
Portable and hard wearing, the THC-detecting devices would produce results within a two-hour time period. When you compare this to the lengthy process of sending urine or saliva samples to a laboratory for testing, the Cannabix Marijuana Breathalyzer is a much more convenient alternative, not to mention less invasive.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Bethan Jenkins
Bethan is a full-time wanderluster, traveler, and digital nomad with 7 years of experience in the freelance writing world. She has mastered the art of beating jet lag and using hammocks as an office for content curation.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Pivot Pharmaceuticals Inc. is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
